Figure 3.
Figure 3. HLA-matched CD56+ cells show cytotoxicity restricted to leukemic CD34+ cells. CD56+ cells were cultured with either recipient CD34+ CML cells or autologous CD34+ cells. (A-B) Colony inhibition assay of electronically sorted autologous or HLA-matched NK or NK-T cells as indicated on patient 7 CD34+ CML cells. (C) Cytotoxicity assay of IL-2–stimulated HLA-matched donor CD56+ cells on CD34+ CML cells of patient 4 (□) or autologous normal CD34+ cells (▪). (D) Cytotoxicity assay of IL-2– and IL-15–stimulated donor HLA-matched CD56+ cells on CD34+ CML cells of patient (□) or autologous normal CD34+ cells (▪). IL-2–stimulated CD56-negative PBLs versus recipient CD34+ CML cells indicated by ○. Error bars indicate plus or minus standard deviation (SD).

HLA-matched CD56+ cells show cytotoxicity restricted to leukemic CD34+ cells. CD56+ cells were cultured with either recipient CD34+ CML cells or autologous CD34+ cells. (A-B) Colony inhibition assay of electronically sorted autologous or HLA-matched NK or NK-T cells as indicated on patient 7 CD34+ CML cells. (C) Cytotoxicity assay of IL-2–stimulated HLA-matched donor CD56+ cells on CD34+ CML cells of patient 4 (□) or autologous normal CD34+ cells (▪). (D) Cytotoxicity assay of IL-2– and IL-15–stimulated donor HLA-matched CD56+ cells on CD34+ CML cells of patient (□) or autologous normal CD34+ cells (▪). IL-2–stimulated CD56-negative PBLs versus recipient CD34+ CML cells indicated by ○. Error bars indicate plus or minus standard deviation (SD).

Close Modal

or Create an Account

Close Modal
Close Modal